Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis.

Qu Y, Wu L, Wang Y, Peng F, Zhang J, Pan D, Wang T, Zhou Y, Xia J, He J, Shi C, Zhao Y, Wang X, Liu R, Zhang Y, Liu J, Wu J, Duan S, Cai G, Li P, Hong Q, Chen X

Open source

DOI
10.1016/j.apsb.2026.06.041
Published
2026 Sep
Container
Acta pharmaceutica Sinica. B
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2026.06.041,
  title = {Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis.},
  author = {Qu Y and Wu L and Wang Y and Peng F and Zhang J and Pan D and Wang T and Zhou Y and Xia J and He J and Shi C and Zhao Y and Wang X and Liu R and Zhang Y and Liu J and Wu J and Duan S and Cai G and Li P and Hong Q and Chen X},
  year = {2026},
  journal = {Acta pharmaceutica Sinica. B},
  doi = {10.1016/j.apsb.2026.06.041},
  url = {https://doi.org/10.1016/j.apsb.2026.06.041}
}

RIS

TY  - JOUR
TI  - Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis.
AU  - Qu Y
AU  - Wu L
AU  - Wang Y
AU  - Peng F
AU  - Zhang J
AU  - Pan D
AU  - Wang T
AU  - Zhou Y
AU  - Xia J
AU  - He J
AU  - Shi C
AU  - Zhao Y
AU  - Wang X
AU  - Liu R
AU  - Zhang Y
AU  - Liu J
AU  - Wu J
AU  - Duan S
AU  - Cai G
AU  - Li P
AU  - Hong Q
AU  - Chen X
PY  - 2026
JO  - Acta pharmaceutica Sinica. B
DO  - 10.1016/j.apsb.2026.06.041
UR  - https://doi.org/10.1016/j.apsb.2026.06.041
ER  - 

APA

Y, Q., L, W., Y, W., F, P., J, Z., D, P., T, W., Y, Z., J, X., J, H., C, S., Y, Z., X, W., R, L., Y, Z., J, L., J, W., S, D., G, C., P, L., Q, H., & X, C. (2026). Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.06.041

Source records